|
         |
|
At Genomic Healthcare Strategies we focus on the changes which are coming under the umbrella phrase “personalized medicine.” To us, personalized medicine means much more than making genomically informed therapeutic decisions. Personalized medicine will radically alter the health care landscape, bringing in new players, changing the power relationships of participants, altering old economic models, creating new economic models, and making informed consumers a major force. We have created GHS to help organizations succeed in this new environment.
Genomic Healthcare Strategies is a company for a new era, where health care is facing disruptive change.
The emergent understanding of the molecular basis of disease is transforming the practice of medicine. This knowledge explosion is producing a new generation of diagnostics and pharmaceuticals that are effecting changes in research, development and clinical trials. Blockbuster drugs have lost their luster, companion diagnostics are the wave of the future and presymptomatic therapies will be the new paradigm for prevention.
At the same time, informed and active consumers are taking charge of their own health care and wellness, paying for genomic and metabolic analyses, and taking action both inside and outside of the traditional health care system. Companies (both agile traditional players and new entrants) are moving to take advantage of the changing space.
A revolution is coming to the way products are regulated, institutions provide services, payors reimburse for services, and physicians address individual patients.
The new era demands new business strategies. Traditional 20th-century thinking, which segregates therapeutics and diagnostics, health care and wellness, patients and customers, reimbursement and self-payment, health care delivery and direct-to-consumer, is not up to the challenges of the rapidly evolving marketplace. To succeed in this uncharted territory requires a vision of the future and a creative and realistic approach.
GHS takes just that approach. The members of our team are strategists, entrepreneurs, senior executives, physicians, economists, and policy-makers with successful track records in medicine, academia, regulatory agencies, and industry. We can supply the operational, strategic, scientific, and financial expertise to take your project, whether the development of new strategies, launch of a product, a service, or a new company, from conception to success in the marketplace.
|
|
|
